Cancer Oriented Understanding and Navigation Via Supportive and Educational Language Models (COUNSEL)

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07836933
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • AI-guided COUNSEL Intervention — BEHAVIORAL
    An AI-guided, interactive educational tool that allows participants to interact with a large language model (LLM) will be delivered via teleconference.
  • Questionnaires — BEHAVIORAL
    Participant and clinicians will complete questionnaires

Study Details

A randomized, open-label behavioral study designed to evaluate the feasibility, acceptability, and early impact of a large language model (LLM)-based artificial intelligence (AI) tool to support patient understanding following an initial oncology consultation.

Key Dates

First listed
Sep 23, 2026
Start date
Oct 31, 2026
Status verified
Sep 2026
Primary completion
Nov 30, 2027
Completion
Apr 30, 2028

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Intervention Arm
    AI teleconferences with Large Language Model (LLM) interaction
  • Placebo Comparator: Control Arm
    AI teleconferences without LLM interaction

Primary Outcome Measure

Mean differences on EORTC QLQ-INFO25 - Patient-Perceived Cancer-Related Information [ Time Frame: Up to 2 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94143
UCSF Genitourinary Medical Oncology Recruitment
[email protected]
877-827-3222
Julian Hong, MD, MS (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

Nationwide
Prostate cancer trialsOncology trialsProstate oncology trialsMen's health trialsUrology trials
By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
University of California, San Francisco· San Francisco, CA

Related Studies